In the most recent trading session, Recursion Pharmaceuticals (RXRX) closed at $3.34, indicating a +1.21% shift from the ...

Cathie Wood's Ark Genomic Revolution ETF has some of its top holdings in innovative health companies like Tempus AI and Twist ...

Your hard-earned money would be better spent elsewhere.

The new "Claude Science" from Anthropic uses artificial intelligence to tackle rare genetic disorders and tropical maladies, ...

Intactis Bio joins the Biocomputing industry, which seeks to deliver lower-energy, cost-efficient computing capacity driven ...

Some of the industry’s most closely-watched AI drugs could provide insight into the success of technology-assisted ...

Full of paradoxes, humor, and heart, these sci-fi books are perfect for anyone missing the time travel antics of the Back to ...

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Incyte , Annexon Biosciences and Celcuity with bullish sentiments. TipRanks Welcom ...

Demis says the web will change significantly into an agent-first web. AI agents won’t need human-style visual renders and ...

Cathie Wood's ARK Invest bought $2.1M of CoreWeave stock after a 30% crash. Here's why she's betting on the AI cloud company ...

Chai Discovery's $400M Series C triples its value to $3.8bn, a fresh sign that AI drug discovery has moved from promise to deployment at big pharma.

Magic: The Gathering’s new Marvel Super Heroes set is here, and as you can probably imagine, it’s absolutely packed with ...